| Literature DB >> 24066725 |
Eva Gad Søndergaard1, Bettina Haastrup Grøne, Christian Nielsen Wulff, Pia Veldt Larsen, Jens Søndergaard.
Abstract
BACKGROUND: The care responsibilities for cancer patients are frequently handed over from one healthcare professional to another. These handovers are known to pose a threat to the safety of patients and the efficiency of the healthcare system. Little is known about specific needs of cancer patients in handovers. The objectives of this study were to examine cancer patients' unmet needs for information and coordination in handovers and to analyse the association between patients' demographic and clinical characteristics and unmet information and coordination needs.Entities:
Mesh:
Year: 2013 PMID: 24066725 PMCID: PMC3850508 DOI: 10.1186/1756-0500-6-378
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Selected items within the domains of information and coordination translated from Danish
| …my cancer disease and treatment | …my examinations and treatments |
| …transport and accommodation | …check-ups |
| …waiting time | …test results |
| …possibilities for social assistance | …complications |
| …possibilities for counseling regarding my job situation | …my physical rehabilitation plan |
| …my psychological condition | |
| …possible changes regarding carrying out daily activities e.g. cleaning, grocery shopping, and personal hygiene | |
| …possibilities for counseling outside the hospital e.g. The Danish Cancer Society | |
| …impact of lifestyle on my cancer disease e.g. diet, physical activity, smoking and alcohol consumption | |
| …possible psychological reactions | |
| …coping with my disease and my next of kin e.g. family and friends | |
| …my sexuality | |
| …alternative treatment e.g. reflexology, acupuncture, healing, and homeopathy |
Figure 1Study flowchart.
Overview of Cronbach’s alpha values
| Overall unmet information needs | 0,97 |
| Unmet information needs at hospital discharge | 0,93 |
| Unmet information needs in handovers between internal hospital departments | 0,90 |
| Unmet informations needs in handovers between hospitals | 0,93 |
| Overall unmet coordination needs | 0,97 |
| Unmet coordination needs in handovers between hospital and GP | 0,97 |
| Unmet coordination needs in handovers between internal hospital departments | 0,93 |
| Unmet coordination needs in handovers between hospitals | 0,96 |
Demographic and clinical characteristics of participants and non-participants
| 131 (52.4) | 119 (47.6) | |
| | | |
| | | |
| Female | 98 (75) | 86 (72) |
| Male | 33 (25) | 33 (28) |
| <60 years | 38 (29) | 40 (34) |
| ≥60 years | 93 (71) | 78 (66) |
| <3 years | 60 (46) | 46 (39) |
| ≥3 years | 70 (54) | 71 (61) |
| | | |
| Not living with a partner | 28 (22) | - |
| Living with a partner | 102 (78) | - |
| | | |
| No children living at home | 114 (89) | - |
| Children living at home | 14 (11) | - |
| | | |
| No higher education | 70 (57) | - |
| Higher education | 56 (44) | - |
| | | |
| Not retired | 47 (37) | - |
| Retired | 80 (63) | - |
| | | |
| | | |
| No comorbidity | 40 (32) | - |
| Comorbidity | 95 (68) | - |
| | | |
| Breast | 90 (71) | 82 (69) |
| Prostate | 27 (21) | 22 (19) |
| Colorectal | 10 (8) | 11 (9) |
| Other | 0 (0) | 3 (3) |
| | | |
| Surgery | 96 (74) | 92 (78) |
| Radiation therapy | 79 (61) | 66 (56) |
| Chemotherapy | 68 (52) | 64 (54) |
| Hormone therapy | 100 (77) | 85 (72) |
| Other pharmaceutical | 17 (13) | 13 (11) |
| Other treatments | 3 (2) | 2 (2) |
| No treatment | 4 (3) | 2 (2) |
*Information on sex, age, years since diagnosis, cancer type and treatment were retrieved by RNs from medical records at the time of assessment.
#Information available only on included patients because information was self-reported, i.e. from the patient questionnaire.
Unmet information needs
| | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gender | ||||||||||||
| Women | 19 (19%) | 1.00 | 1.00 | 14 (16%) | 1.00 | 1.00 | 8 (12%) | 1.00 | 1.00 | 12 (13%) | 1.00 | 1.00 |
| Men | 4 (12%) | 0.57 (0.18; 1.83) | 1.10 (0.31; 3.93) | 4 (25%) | 1.71 (0.48; 6.09) | 2.24 (0.58; 8.64) | 3 (21%) | 2.05 (0.47; 8.94) | 3.31 (0.66; 16.59) | 4 (12%) | 0.97 (0.29; 3.23) | 2.77 (0.63; 11.20) |
| Age | ||||||||||||
| <60 years of age | 13 (33%) | 1.00 | 1.00 | 9 (26%) | 1.00 | 1.00 | 6 (23%) | 1.00 | 1.00 | 9 (24%) | 1.00 | 1.00 |
| ≥60 years of age | 10 (11%) | 0.24*(0.10; 0.62) | 0.26*(0.10; 0.70) | 9 (13%) | 0.42 (0.15; 1.19) | 0.36 (0.12; 1.07) | 5 (9%) | 0.33 (0.09; 1.19) | 0.26 (0.07; 1.05) | 7 (8%) | 0.27*(0.09; 0.79) | 0.23*(0.07; 0.80) |
| Marital status | ||||||||||||
| No partner | 8 (29%) | 1.00 | 1.00 | 7 (29%) | 1.00 | 1.00 | 2 (13%) | 1.00 | 1.00 | 5 (19%) | 1.00 | 1.00 |
| Partner | 15 (15%) | 0.43 (0.16; 1.16) | 0.39 (0.13; 1.16) | 11 (14%) | 0.40 (0.13; 1.18) | 0.39 (0.12; 1.24) | 9 (13%) | 1.01 (0.19; 5.23) | 0.63 (0.10; 3.78) | 11 (11%) | 0.54 (0.17; 1.71) | 0.47 (0.12; 1.88) |
| Education | ||||||||||||
| Not higher education | 7 (10%) | 1.00 | 1.00 | 6 (12%) | 1.00 | 1.00 | 4 (9%) | 1.00 | 1.00 | 2 (3%) | 1.00 | 1.00 |
| Higher education | 16 (29%) | 3.60*(1.36; 9.52) | 3.41*(1.23; 9.44) | 12 (24%) | 2.43 (0.83; 7.11) | 2.53 (0.84; 7.59) | 7 (19%) | 2.28 (0.61; 8.49) | 2.72 (0.67; 11.09) | 14 (26%) | 11.90*(2.57; 55.08) | 13.88*(2.78; 67.23) |
| Comorbidity | ||||||||||||
| No comorbidity | 8 (20%) | 1.00 | 1.00 | 6 (19%) | 1.00 | 1.00 | 4 (14%) | 1. 00 | 1.00 | 4 (10%) | 1.00 | 1.00 |
| Yes comorbidity | 15 (16%) | 0.79 (0.30; 2.07) | 1.35 (0.45; 4.05) | 12 (18%) | 0.93 (0.31; 2.75) | 1.33 (0.40; 4.38) | 7 (14%) | 1.02 (0.27; 3.82) | 2.17 (0.43; 10.91) | 12 (14%) | 1.46 (0.44; 4.85) | 3.51 (0.82; 15.09) |
| Surgery | ||||||||||||
| No surgery | 3 (9%) | 1.00 | 1.00 | 3 (21%) | 1.00 | 1.00 | 3 (20%) | 0.55 | 1.00 | 3 (9%) | 1.00 | 1.00 |
| Surgery | 20 (21%) | 2.72 (0.75; 9.81) | 2.98 (0.35; 25.77) | 15 (17%) | 0.76 (0.19; 3.07) | 1.21 (0.12; 12.24) | 8 (12%) | 0.54 (0.13; 2.35) | 0.63 (0.02; 15.89) | 13 (14%) | 1.66 (0.44; 6.22) | 3.30 (0.23; 46.73) |
| Radiation | ||||||||||||
| No radiation | 10 (20%) | 1.00 | 1.00 | 10 (30%) | 1.00 | 1.00 | 2 (15%) | 1.00 | 1.00 | 7 (14%) | 1.00 | 1.00 |
| Radiation | 13 (16%) | 0.81 (0.32; 2.01) | 0.73 (0.26; 2.01) | 8 (12%) | 0.31*(0.11; 0.87) | 0.33 (0.11; 1.01) | 9 (13%) | 0.83 (0.16; 4.35) | 0.75 (0.13; 4.42) | 9 (12%) | 0.83 (0.29; 2.40) | 0.93 (0.28; 3.11) |
| Chemotherapy | ||||||||||||
| No chemotherapy | 8 (13%) | 1.00 | 1.00 | 7 (17%) | 1.00 | 1.00 | 5 (14%) | 1.00 | 1.00 | 8 (13%) | 1.00 | 1.00 |
| Chemotherapy | 15 (22%) | 1.91 (0.75; 4.88) | 1.10 (0.30; 4.06) | 11 (18%) | 1.09 (0.38; 3.09) | 1.21 (0.31; 4.82) | 6 (13%) | 0.98 (0.27; 3.53) | 1.15 (0.18; 7.53) | 8 (12%) | 0.93 (0.33; 2.65) | 0.43 (0.08; 2.26) |
| Hormones | ||||||||||||
| No hormones | 8 (27%) | 1.00 | 1.00 | 6 (26%) | 1.00 | 1.00 | 3 (19%) | 1.00 | 1.00 | 3 (10%) | 1.00 | 1.00 |
| Hormones | 15 (15%) | 0.49 (0.18; 1.29) | 0.45 (0.15; 1.33) | 12 (15%) | 0.52 (0.17; 1.57) | 0.50 (0.15; 1.67) | 8 (12%) | 0.60 (0.14; 2.57) | 0.50 (0.10; 2.52) | 13 (13%) | 1.31 (0.35; 4.95) | 1.38 (0.30; 6.40) |
| <3 years | 11 (18%) | 1.00 | 1.00 | 7 (16%) | 1.00 | 1.00 | 6 (15%) | 1.00 | 1.00 | 9 (16%) | 1.00 | 1.00 |
| ≥3 years | 12 (17%) | 0.92 (0.37; 2.27) | 0.99(0.35; 2.78) | 11 (19%) | 1.26 (0.45;3.58) | 1.65(0.50; 5.47) | 5 (12%) | 0.81 (0.23; 2.90) | 1.00 (0.24; 4.15) | 7 (10%) | 0.60 (0.21; 1.74) | 0.81(0.23; 2.87) |
aAdjusted for age, gender and education, * P < 0.050, #Consists of 102 patient responses, ##Consists of 82 patient responses, ###Consists 129 patient responses.
Unmet coordination needs
| | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gender | ||||||||||||
| Women | 19 (19%) | 1.00 | 1.00 | 17 (20%) | 1.00 | 1.00 | 8 (9%) | 1.00 | 1.00 | 14 (18%) | 1.00 | 1.00 |
| Men | 5 (15%) | 0.74 (0.25; 2.18) | 1.10 (0.31; 3.93) | 4 (13%) | 0.63 (0.19; 2.06) | 0.88 (0.25; 3.09) | 2 (6%) | 0.74 (0.15; 3.69) | 2.53 (0.37; 17.47) | 5 (24%) | 1.45 (0.46; 4.62) | 1.85a(0.48; 7.07) |
| Age | ||||||||||||
| <60 years of age | 14 (36%) | 1.00 | 1.00 | 9 (29%) | 1.00 | 1.00 | 7 (19%) | 1.00 | 1.00 | 9 (29%) | 1.00 | 1.00 |
| ≥60 years of age | 10 (11%) | 0.22*(0.09; 0.55) | 0.26*(0.10; 0.70) | 12 (14%) | 0.40 (0.15; 1.06) | 0.44 (0.16; 1.25) | 3 (3%) | 0.16*(0.04; 0.65) | 0.14*(0.03; 0.68) | 10 (14%) | 0.41 (0.15; 1.15) | 0.46b(0.15; 1.37) |
| Marital status | ||||||||||||
| No Partner | 5 (18%) | 1.00 | 1.00 | 3 (12%) | 1.00 | 1.00 | 2 (7%) | 1.00 | 1.00 | 4 (18%) | 1.00 | 1.00 |
| Partner | 19 (19%) | 1.05 (0.33; 3.13) | 1.06 (0.32; 3.50) | 18 (20%) | 1.81 (0.49; 6.71) | 2.05 (0.51; 8.16) | 8 (8%) | 1.12 (0.22; 5.59) | 1.52 (0.24; 9.55) | 15 (19%) | 1.07 (0.32; 3.63) | 0.91c(0.25; 3.28) |
| Education | ||||||||||||
| Not higher education | 7 (10%) | 1.00 | 1.00 | 8 (12%) | 1.00 | 1.00 | 1 (1%) | 1.00 | 1.00 | 7 (13%) | 1.00 | 1.00 |
| Higher education | 16 (29%) | 3.06*(1.36; 9.52) | 3.41*(1.23; 9.44) | 13 (28%) | 2.91*(1.09; 7.73) | 2.82*(1.04; 7.63) | 9 (17%) | 13.02*(1.60; 106.25) | 14.22*(1.61; 125.79) | 11 (26%) | 2.31 (0.81; 6.59) | 2.47d(0.82; 7.37) |
| Comorbidity | ||||||||||||
| No comorbidity | 10 (25%) | 1.00 | 1.00 | 6 (18%) | 1.00 | 1.00 | 5 (13%) | 1. 00 | 1.00 | 7 (21%) | 1.00 | 1.00 |
| Yes comorbidity | 12 (14%) | 0.49 (0.19; 1.26) | 0.75 (0.26; 2.13) | 14 (18%) | 0.99 (0.35; 2.84) | 1.24 (0.41; 3.80) | 5 (6%) | 0.44 (0.12; 1.63) | 0.83 (0.19; 3.67) | 11 (17%) | 0.82 (0.28; 2.34) | 1.15c(0.35; 3.78) |
| Surgery | ||||||||||||
| No surgery | 3 (9%) | 1.00 | 1.00 | 5 (16%) | 1.00 | 1.00 | 2 (6%) | 0.55 | 1.00 | 3 (14%) | 1.00 | 1.00 |
| Surgery | 21 (22%) | 2.89 (0.80; 10.41) | 2.98 (0.35; 25.77) | 16 (19%) | 1.27 (0.42; 3.81) | 0.37 (0.05; 3.04) | 8 (9%) | 1.43 (0.29; 7.08) | 0.63 (0.04; 9.04) | 16 (21%) | 1.55 (0.41; 5.91) | 6.06c(0.33; 110.58) |
| Radiation | ||||||||||||
| No radiation | 9 (18%) | 1.00 | 1.00 | 6 (13%) | 1.00 | 1.00 | 4 (8%) | 1.00 | 1.00 | 7 (27%) | 1.00 | 1.00 |
| Radiation | 15 (19%) | 1.09 (0.44; 2.73) | 1.26 (0.44; 3.56) | 15 (21%) | 1.74 (0.62; 4.88) | 1.80 (0.60; 5.42) | 6 (8%) | 0.96 (0.26; 3.58) | 1.14 (0.26; 5.01) | 12 (16%) | 0.53 (0.18; 1.55) | 0.57c(0.18; 1.82) |
| Chemotherapy | ||||||||||||
| No chemotherapy | 8 (13%) | 1.00 | 1.00 | 7 (12%) | 1.00 | 1.00 | 4 (7%) | 1.00 | 1.00 | 10 (23%) | 1.00 | 1.00 |
| Chemotherapy | 16 (24%) | 2.08 (0.82; 5.27) | 1.10 (0.30; 4.06) | 14 (24%) | 2.22 (0.82; 6.00) | 1.91 (0.49; 7.44) | 6 (9%) | 1.35 (0.36; 5.04) | 0.54 (0.07; 4.17) | 9 (16%) | 0.67 (0.24; 1.82) | 0.34c(0.08; 1.38) |
| Hormones | ||||||||||||
| No hormones | 9 (30%) | 1.00 | 1.00 | 9 (38%) | 1.00 | 1.00 | 2 (7%) | 1.00 | 1.00 | 5 (23%) | 1.00 | 1.00 |
| Hormones | 15 (15%) | 0.41 (0.16; 1.07) | 0.45 (0.15; 1.33) | 12 (13%) | 0.25*(0.09; 0.70) | 0.21*(0.07; 0.66) | 8 (8%) | 1.24 (0.25; 6.20) | 1.39 (0.23; 8.55) | 14 (18%) | 0.75 (0.24; 2.39) | 0.87c(0.24; 3.11) |
| <3 years | 12 (20%) | 1.00 | 1.00 | 11 (22%) | 1.00 | 1.00 | 6 (10%) | 1.00 | 1.00 | 8 (17%) | 1.00 | 1.00 |
| ≥3 years | 12 (17%) | 0.83 (0.34; 2.01) | 0.99 (0.35; 2.78) | 10 (15%) | 0.66 (0.26; 1.71) | 0.61 (0.21; 1.76) | 4 (6%) | 0.56 (0.15; 2.10) | 0.73 (0.16; 3.38) | 11 (22%) | 1.38 (0.50; 3.38) | 1.98c(0.63; 6.25) |
aAdjusted for age, gender and education, *P < 0.050, #Consists of 117 patient responses, ##Consists of 125 patient responses, ###Consists of 100 patient responses.